BridgeBio Pharma (BBIO) News Today $47.75 +0.38 (+0.80%) Closing price 04:00 PM EasternExtended Trading$47.64 -0.11 (-0.23%) As of 05:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BBIO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period BridgeBio Pharma Inc (BBIO) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 4 at 9:39 AM | finance.yahoo.comBIT Capital GmbH Purchases 282,731 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 4 at 8:32 AM | marketbeat.comAllianz Asset Management GmbH Takes Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 4 at 4:28 AM | marketbeat.comXTX Topco Ltd Has $1.20 Million Stock Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)August 3 at 4:00 AM | marketbeat.comAlnylam: Amvuttra Is Just Getting StartedJuly 31, 2025 | seekingalpha.comRaymond James Financial Initiates Coverage on BridgeBio Pharma (NASDAQ:BBIO)July 31, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Earns Overweight Rating from Cantor FitzgeraldJuly 31, 2025 | americanbankingnews.comBiotech Has Been Stalling. 3 Stocks That Could See Healthy Gains.July 30, 2025 | barrons.comBridgeBio Pharma (BBIO) Projected to Post Quarterly Earnings on TuesdayJuly 30, 2025 | marketbeat.comCantor Fitzgerald Reiterates Overweight Rating for BridgeBio Pharma (NASDAQ:BBIO)July 30, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Grows Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)July 29, 2025 | marketbeat.comVictory Capital Management Inc. Purchases 14,825 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)July 29, 2025 | marketbeat.com6,618 Shares in BridgeBio Pharma, Inc. (NASDAQ:BBIO) Purchased by Cerity Partners LLCJuly 29, 2025 | marketbeat.comAnalysts Set BridgeBio Pharma, Inc. (NASDAQ:BBIO) Price Target at $61.50July 28, 2025 | americanbankingnews.comWall Street Zen Downgrades BridgeBio Pharma (NASDAQ:BBIO) to SellJuly 28, 2025 | americanbankingnews.comRoyce & Associates LP Acquires 46,994 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)July 27, 2025 | marketbeat.comContrasting Evoke Pharma (NASDAQ:EVOK) & BridgeBio Pharma (NASDAQ:BBIO)July 27, 2025 | americanbankingnews.comBridgeBio Pharma (NASDAQ:BBIO) Stock Rating Lowered by Wall Street ZenJuly 26, 2025 | marketbeat.comLeerink Partners Maintains a Buy on BridgeBio Pharma (BBIO) With a $56 PTJuly 26, 2025 | msn.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of "Buy" by AnalystsJuly 25, 2025 | marketbeat.comLegato Capital Management LLC Acquires 13,401 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)July 25, 2025 | marketbeat.comTruist Sees Upside in BridgeBio Pharma’s (BBIO) ATTR-CM StrategyJuly 25, 2025 | finance.yahoo.comNovel Human Genetics Evidence Confirms Estimates of Genetic Prevalence, Underdiagnosis, and Potentially Greater Symptom Burden of Gain-of-Function CASR Variants Associated with ADH1July 23, 2025 | globenewswire.comTruist Securities Initiates Coverage of BridgeBio Pharma (BBIO) with Buy RecommendationJuly 22, 2025 | msn.comBridgeBio to Host Second Quarter 2025 Financial Results Conference Call on Tuesday, August 5, 2025 at 4:30 pm ETJuly 22, 2025 | globenewswire.comBridgeBio Pharma (NASDAQ:BBIO) Now Covered by Analysts at Truist FinancialJuly 21, 2025 | marketbeat.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Harrow Health (HROW), BridgeBio Pharma (BBIO) and Merck & Company (MRK)July 20, 2025 | theglobeandmail.comLeerink Partnrs Issues Optimistic Estimate for BBIO EarningsJuly 17, 2025 | marketbeat.comScotiabank Sticks to Its Buy Rating for BridgeBio Pharma (BBIO)July 16, 2025 | theglobeandmail.comBridgeBio Pharma (NASDAQ:BBIO) Hits New 12-Month High - What's Next?July 16, 2025 | marketbeat.comEquities Analysts Offer Predictions for BBIO FY2025 EarningsJuly 16, 2025 | marketbeat.comJefferies Initiates Coverage of BridgeBio Pharma (BBIO) with Buy RecommendationJuly 15, 2025 | msn.comFY2028 Earnings Estimate for BBIO Issued By Leerink PartnrsJuly 15, 2025 | marketbeat.comPiper Sandler Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) StockJuly 14, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Now Covered by Jefferies Financial GroupJuly 14, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Makes New $251,000 Investment in BridgeBio Pharma, Inc. (NASDAQ:BBIO)July 12, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Stock Price Expected to Rise, Citigroup Analyst SaysJuly 11, 2025 | marketbeat.comCaas Capital Management LP Takes $297,000 Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)July 11, 2025 | marketbeat.comOppenheimer Upgrades BridgeBio Pharma (BBIO)July 10, 2025 | msn.comBridgeBio Pharma (NASDAQ:BBIO) Hits New 52-Week High - Time to Buy?July 9, 2025 | marketbeat.comOppenheimer Upgrades BridgeBio Pharma (NASDAQ:BBIO) to OutperformJuly 9, 2025 | marketbeat.comBridgeBio Pharma (BBIO) Opinions on $300 Million Royalty Financing Deal - NasdaqJuly 8, 2025 | nasdaq.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Stock Holdings Increased by Principal Financial Group Inc.July 7, 2025 | marketbeat.comBridgeBio Pharma Raises $300M Through Partial European Royalty Monetization for BEYONTTRAJuly 6, 2025 | msn.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Acquired by Cambridge Investment Research Advisors Inc.July 6, 2025 | marketbeat.comNeil Kumar Sells 40,000 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) StockJuly 3, 2025 | marketbeat.comLeerink Partnrs Expects Lower Earnings for BridgeBio PharmaJuly 3, 2025 | marketbeat.comBridgeBio (BBIO) Tanks After Selling Beyonttra Royalty RightsJuly 3, 2025 | msn.comInsider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) Major Shareholder Sells 3,500,000 Shares of StockJuly 2, 2025 | insidertrades.comGlobal Investors Lp Viking Sells 3,500,000 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) StockJuly 1, 2025 | marketbeat.com Get BridgeBio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address BBIO Media Mentions By Week BBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBIO News Sentiment▼0.680.46▲Average Medical News Sentiment BBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBIO Articles This Week▼159▲BBIO Articles Average Week Get BridgeBio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BeOne Medicines News BioNTech News Summit Therapeutics News Insmed News Teva Pharmaceutical Industries News Genmab A/S News Moderna News Dr. Reddy's Laboratories News QIAGEN News Viatris News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBIO) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersThe biggest Gold Rush of our lives is here — and Buffett knows itSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredElon + Nvidia + ?????Nvidia’s H100 chip has been the crown jewel of AI computing—until now. Elon Musk has just teamed up with Nvidi...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BridgeBio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBIO Stock Alerts